GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellCura ASA (OSL:CELL) » Definitions » Beta

CellCura ASA (OSL:CELL) Beta : N/A (As of May. 03, 2024)


View and export this data going back to . Start your Free Trial

What is CellCura ASA Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-03), CellCura ASA's Beta is Not available.


CellCura ASA Beta Historical Data

The historical data trend for CellCura ASA's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellCura ASA Beta Chart

CellCura ASA Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Beta
Get a 7-Day Free Trial - - - 1.10 0.85

CellCura ASA Quarterly Data
Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.12 1.20 0.85 0.83 0.74

Competitive Comparison of CellCura ASA's Beta

For the Biotechnology subindustry, CellCura ASA's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellCura ASA's Beta Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellCura ASA's Beta distribution charts can be found below:

* The bar in red indicates where CellCura ASA's Beta falls into.



CellCura ASA Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


CellCura ASA  (OSL:CELL) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


CellCura ASA Beta Related Terms

Thank you for viewing the detailed overview of CellCura ASA's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


CellCura ASA (OSL:CELL) Business Description

Traded in Other Exchanges
N/A
Address
Unionsgata 18, Skien, NOR, 3732
CellCura ASA is engaged in the development of novel equipment & products for use in Assisted Reproductive Technology & Stem Cell Research globally. The company also offers software solutions used in ART lab for securing the storage & management of data.